Cure CMD

Compiled by PlainTrial · August 8, 2026

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Cure CMD sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting 2 completed upper quartile by trial count

Cure CMD: 3 sponsored US clinical trials, 1 recruiting.

Cure CMD sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Alpha-Dystroglycanopathy (LGMDR13 FKTN Related (Formerly LGMD2M)), with 1 trials.

Cure CMD sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

NCT01403402

COMPLETED

Myotubular Myopathy Event Study

NCT01840657

COMPLETED

Myotubular Myopathy Genetic Testing Study

NCT01817946

Therapeutic Areas

Alpha-Dystroglycanopathy (LGMDR13 FKTN Related (Formerly LGMD2M)) 1

Alpha-Dystroglycanopathy (LGMDR11 POMT1 Related (Formerly LGMD2K)) 1

Alpha-Dystroglycanopathy (LGMDR09 FKRP Related (Formerly LGMD2I)) 1

Alpha-Dystroglycanopathy (Fukuyama CMD) 1

Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C)) 1

Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan) 1

Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations) 1

Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy) 1

Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency 1

X-Linked Myotubular Myopathy 1

What is open in the Cure CMD pipeline

1 recruiting of 3 indexed (33% open); 2 completed (67%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Alpha-Dystroglycanopathy (LGMDR13 FKTN Related (Formerly LGMD2M)) (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Cure CMD: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Cure CMD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Cure CMD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

10xBio · 3 trials · 0% recruiting
22nd Century Group · 3 trials · 0% recruiting
AA Secord · 3 trials · 0% recruiting
AAADRS Clinical Research Center · 3 trials · 0% recruiting

Sponsors near 33% open enrollment (± trial volume)

Aadi Bioscience · 33% recruiting · 9 trials
Aaron Cook · 33% recruiting · 3 trials
Abivax S.A. · 33% recruiting · 6 trials
Actuated Medical · 33% recruiting · 3 trials

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Cure CMD page

3 registered trials is a research-attention snapshot, not an endorsement of Cure CMD or any single study.

1 of Cure CMD's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
Alpha-Dystroglycanopathy (LGMDR13 FKTN Related (Formerly LGMD2M)) is the condition Cure CMD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alpha-Dystroglycanopathy (LGMDR13 FKTN Related (Formerly LGMD2M)) trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Cure CMD pipeline card: 3 registered trials from official public datasets.Report a data error.